{
    "2018-05-09": [
        [
            {
                "time": "",
                "orginal_text": "东吴医药行业周观点：HPV 9价疫苗8天评审通过、抗癌药物大幅减税 ，从研发评审到支付优惠 ，政策全面鼓励药品创新",
                "features": {
                    "keywords": [
                        "HPV疫苗",
                        "抗癌药物",
                        "减税",
                        "政策",
                        "药品创新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "[推荐评级]医药生物行业2018年一季报和2017年业绩回顾：板块增速回升 关注优质白马及高成长个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一季报",
                        "业绩回顾",
                        "板块增速",
                        "优质白马",
                        "高成长个股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "[推荐评级]医药行业周报：继续看好 建议加配二线细分龙头",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "看好",
                        "二线细分龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "只需7个一字板 药明康德市值将比肩华大基因",
                "features": {
                    "keywords": [
                        "药明康德",
                        "市值",
                        "一字板",
                        "华大基因"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}